1. Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study Mukai, Hirofumi, Yamaguchi, Takeshi, Takahashi, Masato, Hozumi, Yasuo, Fujisawa, Tomomi, Ohsumi, Shozo, Akabane, Hiromitsu, Nishimura, Reiki, Takashima, Tsutomu, Park, Youngjin, Sagara, Yasuaki, Toyama, Tatsuya, Imoto, Shigeru, Mizuno, Toshiro, Yamashita, Satoshi, Fujii, Satoshi, Uemura, Yukari British journal of cancer (2020)
2. Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer Matsunuma, Ryoichi, Watanabe, Toru, Hozumi, Yasuo, Koizumi, Kei, Ito, Yasushi, Maruyama, Shoko, Ogura, Hiroyuki, Goto, Keigo, Mori, Hiroki, Sawai, Noriko, Shiiya, Norihiko Breast cancer (Tokyo, Japan) 2020 (2020)
3. Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study Ohno, Shinji, Mukai, Hirofumi, Narui, Kazutaka, Hozumi, Yasuo, Miyoshi, Yasuo, Yoshino, Hiroshi, Doihara, Hiroyoshi, Suto, Akihiko, Tamura, Motoshi, Morimoto, Takashi, Zaha, Hisamitsu, Chishima, Takashi, Nishimura, Reiki, Ishikawa, Takashi, Uemura, Yukari, Ohashi, Yasuo BREAST CANCER RESEARCH AND TREATMENT 176 (3) 631 - 635 (2019)
4. HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer Kitahara, Miyuki, Hozumi, Yasuo, Nakamura, Ayaka, Tachi, Kana, Saitoh, Hitoaki, Iijima, Tatsuo Case reports in oncology 12 (2) 473 - 479 (2019)
5. HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer Kitahara, Miyuki, Hozumi, Yasuo, Nakamura, Ayaka, Tachi, Kana, Saitoh, Hitoaki, Iijima, Tatsuo Case reports in oncology 12 (2) 473 - 479 (2019)
6. Evaluation of oral S-1 as a first-line chemotherapy for metastatic HER2-negative breast cancer: An analysis of two randomized phase III studies (SELECT BC-CONFIRM and SELECT BC) Nishimura, Reiki, Mukai, Hirofumi, Uemura, Yukari, Akabane, Hiromitsu, Park, Youngjin, Takahashi, Masato, Sagara, Yoshiaki, Takashima, Tsutomu, Fujisawa, Tomomi, Hozumi, Yasuo, Kawahara, Takuya, Watanabe, Takanori JOURNAL OF CLINICAL ONCOLOGY 37 (15::S) (2019)
7. A prospective randomized multi-center open-label phase III trial of extending aromatase-inhibitor adjuvant therapy to 10 years - Results from 1697 postmenopausal women in the N-SAS BC 05 trial: Arimidex extended adjuvant randomized study (AERAS) Ohtani, S, Iijima, K, Higaki, K, Sato, Y, Hozumi, Y, Hasegawa, Y, Takei, H, Tanaka, M, Yagata, H, Masuoka, H, Tanabe, M, Egawa, C, Komoike, Y, Saji, S, Nakamura, T, Yanagita, Y, Ohtsu, H, Mukai, H, Iwase, T CANCER RESEARCH 79 (4::S) (2019)
8. Randomized phase 3 study of anthracycline-containing regimens versus S-1 as first-line treatment for metastatic breast cancer (SELECT BC-CONFIRM)-A combined analysis of two randomized phase 3 studies (SELECT BC-CONFIRM and SELECT BC)- Park, Y, Akabane, H, Watanabe, T, Takahashi, M, Sagara, Y, Nishimura, R, Tsurutani, J, Takashima, T, Fujisawa, T, Hozumi, Y, Uemura, Y, Mukai, H CANCER RESEARCH 79 (4::S) (2019)
9. Bowen's Disease of the Nipple Kitahara, Miyuki, Hozumi, Yasuo, Watanabe, Akie, Iijima, Tatsuo Case reports in oncology 11 (3) 609 - 614 (2018)
10. Intramammary Metastasis in a Patient with a History of Renal Cell Carcinoma: A Case Report Kitahara, Miyuki, Hozumi, Yasuo, Asada, Rio, Sawa, Aya, Saito, Hitoaki, Iijima, Tatsuo Case reports in oncology 11 (2) 318 - 322 (2018)

researchmap の論文リストを表示する Show the publication list on researchmap